News

BD is set to commence a multi-centre registry study, XTRACT, of the Rotarex Atherectomy System, for peripheral artery disease ...
SAGA Diagnostics has commercially launched the multi-cancer molecular residual disease (MRD) platform, Pathlight, in the US.
The CEO of Flow Neuroscience has called out the US Food and Drug Administration (FDA) for market entry delays for clinically ...
Danish medtech Brainreader has secured $7.3m (€6.6m) to support the market rollout of Neuroreader, its artificial ...
The US Food and Drug Administration (FDA) has granted approval for Abbott's Tendyne transcatheter mitral valve replacement ...
With the 78th World Health Assembly ending today, all eyes have been on this year’s World Health Organization (WHO) member’s ...
SeekIn has announced the clinical validation of its SeekInCare blood test, intended for the early identification of various ...
Surgify Medical has secured €7m ($7.97m) in Series A funding to expand the reach of its Surgify Halo technology.
Zylox-Tonbridge Medical Technology has received regulatory approval for its ZYLOX Unicorn vascular closure device (VCD) in ...
A team at the University of Melbourne has developed a new blood test for the diagnosis of rare genetic diseases in babies and ...
Route 92 Medical has announced that its HiPoint Reperfusion System, including the .088in HiPoint 88 aspiration catheter, has ...
Neurostimulation is reshaping the treatment of urinary incontinence, offering minimally invasive relief through smarter and ...